Outpost Bio Raises $3.5 M Pre-Seed to Build Frontier Models for Human Microbiology
Outpost Bio, a deep-tech company making human microbiology computable, today announced its $3.5M pre-seed funding round led by Seedcamp and Merantix, with participation from OpenSeed VC and Defined Capital.
The company is building frontier AI models trained on proprietary data from human-derived microbial communities. Its Lab-in-the-Loop platform combines high-throughput biological assays with causal AI to predict how molecules interact with the human microbiome — enabling any partner developing molecules that go into or onto humans to predict microbe-mediated metabolism, toxicity, and response.
“We’re building the most comprehensive dataset in human microbiology,” said Jenny Yang, CEO & Co-Founder. “For the first time, we can move beyond correlations to reveal causal pathways that determine how the human body interacts with therapeutic and consumer compounds.”
read more
Work on a problem that matters.
Our mission is ambitious, and our standards are high. Our culture is built on intellectual honesty, deep ownership, reliably doing what we say we will do. If you are a builder who thrives on candid feedback and are ready to do the best work of your career, we would love to meet you.
An open invitation to researchers.
We’re building AI to predict how interventions impact the human microbiome and will be contributing foundational datasets and models back to the scientific community. We’re seeking collaborators with rich pre/post-intervention datasets of the microbiome. We'll offer partners rich insights to existing datasets.
© Outpost Bio 2025
Design by The Sourdough
